TINA AMIDEI: Open Payments
NPI 1285693234 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$368 in 17 payments from 9 companies in 2025. Trend: 2023 $732 · 2024 $909 · 2025 $368
Food & beverage: $368
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 5 | $118 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| Merck Sharp & Dohme LLC | 3 | $51 |
| Recor Medical Inc | 1 | $32 |
| Abbott Laboratories | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| PFIZER INC. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $18 |
Products named: Assure WCD, VERQUVO, Paradise Ultrasound Renal Denervation System, LEQVIO, ENTRESTO, CARDIOMEMS, VYNDAQEL, JARDIANCE.
Industry payments across GA — which companies pay providers there.
